Nomura Asset Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.88M | Sell |
18,237
-5,655
| -24% | -$3.18M | 0.02% | 468 |
|
|
2026
Q1 | $14.2M | Buy |
23,892
+2,500
| +12% | +$1.25M | 0.04% | 366 |
|
|
2025
Q4 | $10.4M | Buy |
21,392
+8,446
| +65% | +$3.93M | 0.03% | 437 |
|
|
2025
Q3 | $5.43M | Sell |
12,946
-123
| -0.9% | -$41.4K | 0.01% | 580 |
|
|
2025
Q2 | $3.76M | Sell |
13,069
-8,477
| -39% | -$2.53M | 0.01% | 635 |
|
|
2025
Q1 | $6.64M | Sell |
21,546
-3,075
| -12% | -$1.05M | 0.02% | 523 |
|
|
2024
Q4 | $8.69M | Sell |
24,621
-1,016
| -4% | -$373K | 0.03% | 449 |
|
|
2024
Q3 | $9.19M | Sell |
25,637
-2,908
| -10% | -$982K | 0.03% | 425 |
|
|
2024
Q2 | $9.09M | Sell |
28,545
-2,524
| -8% | -$668K | 0.03% | 400 |
|
|
2024
Q1 | $7.14M | Buy |
31,069
+75
| +0.2% | +$16.9K | 0.03% | 460 |
|
|
2023
Q4 | $6.82M | Buy |
30,994
+7,971
| +35% | +$1.84M | 0.03% | 459 |
|
|
2023
Q3 | $5.2M | Sell |
23,023
-10,286
| -31% | -$2.37M | 0.02% | 491 |
|
|
2023
Q2 | $7.35M | Buy |
33,309
+10,411
| +45% | +$2.31M | 0.03% | 424 |
|
|
2023
Q1 | $5.13M | Buy |
22,898
+16,502
| +258% | +$4.07M | 0.03% | 474 |
|
|
2022
Q4 | $1.78M | Buy |
6,396
+6,136
| +2,360% | +$1.55M | 0.01% | 721 |
|
|
2022
Q3 | $54.4K | Hold |
260
| – | – | ﹤0.01% | 1014 |
|
|
2022
Q2 | $61.3K | Hold |
260
| – | – | ﹤0.01% | 1020 |
|
|
2022
Q1 | $46.6K | Hold |
260
| – | – | ﹤0.01% | 1105 |
|
|
2021
Q4 | $56.2K | Hold |
260
| – | – | ﹤0.01% | 984 |
|
|
2021
Q3 | $48K | Buy |
+260
| New | +$51.2K | ﹤0.01% | 952 |
|
|
2019
Q2 | – | Sell |
-7,138
| Closed | -$838K | – | 992 |
|
|
2019
Q1 | $838K | Hold |
7,138
| – | – | 0.01% | 787 |
|
|
2018
Q4 | $777K | Buy |
7,138
+1,100
| +18% | +$128K | 0.01% | 758 |
|
|
2018
Q3 | $772K | Sell |
6,038
-7,636
| -56% | -$944K | 0.01% | 791 |
|
|
2018
Q2 | $1.55M | Sell |
13,674
-25
| -0.2% | -$2.75K | 0.02% | 626 |
|
|
2018
Q1 | $1.54M | Buy |
13,699
+150
| +1% | +$19.1K | 0.02% | 603 |
|
|
2017
Q4 | $2M | Buy |
13,549
+8,496
| +168% | +$1.08M | 0.02% | 510 |
|
|
2017
Q3 | $592K | Sell |
5,053
-7,636
| -60% | -$975K | 0.01% | 796 |
|
|
2017
Q2 | $1.65M | Buy |
12,689
+43
| +0.3% | +$5.36K | 0.02% | 533 |
|
|
2017
Q1 | $1.71M | Buy |
12,646
+40
| +0.3% | +$6.06K | 0.02% | 515 |
|
|
2016
Q4 | $1.81M | Hold |
12,606
| – | – | 0.03% | 454 |
|
|
2016
Q3 | $1.49M | Hold |
12,606
| – | – | 0.03% | 517 |
|
|
2016
Q2 | $1.33M | Hold |
12,606
| – | – | 0.03% | 519 |
|
|
2016
Q1 | $1.41M | Buy |
+12,606
| New | +$1.6M | 0.03% | 512 |
|
|
2015
Q4 | – | Sell |
-4,650
| Closed | -$610K | – | 899 |
|
|
2015
Q3 | $610K | Hold |
4,650
| – | – | 0.01% | 753 |
|
|
2015
Q2 | $809K | Buy |
+4,650
| New | +$836K | 0.02% | 682 |
|
Other funds holding UTHR
ACA
JT
Nomura Asset Management's UTHR Position: Q2 2026 in Review
Nomura Asset Management reduced its United Therapeutics (UTHR) stake by 24% in Q2 2026, selling an estimated $3.18M and leaving 18,237 shares worth $9.88M. The position accounts for 0.02% of the portfolio, ranked #468.
Nomura Asset Management first reported a position in UTHR in Q2 2015 and has held it in 35 quarters since. The position peaked at $14.2M in Q1 2026. 874 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Nomura Asset Management held 18,237 shares of United Therapeutics worth $9.88M as of Q2 2026.
- Nomura Asset Management sold 5,655 United Therapeutics shares in Q2 2026, an estimated $3.18M.
- United Therapeutics made up 0.02% of Nomura Asset Management's portfolio in Q2 2026, its #468 holding.
- Nomura Asset Management first reported a position in United Therapeutics in Q2 2015 and has held it in 35 quarters since.
- Nomura Asset Management's United Therapeutics position peaked at $14.2M in Q1 2026.
- 874 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.